New agents for the treatment of systemic fungal infections – current status
- 1 May 2002
- journal article
- Published by Taylor & Francis in Emerging Drugs
- Vol. 7 (1) , 3-32
- https://doi.org/10.1517/14728214.7.1.3
Abstract
Systemic antifungal chemotherapy is enjoying its most dynamic era. More antifungal agents are under development than ever before, including agents in entirely new classes. Major goals of current investigations are to identify compounds with a wide spectrum of activity, minimal toxicity and a high degree of target specificity. The antifungal drugs in development include new azoles {voriconazole, posaconazole (formerly SCH-56592), ravuconazole (formerly BMS-207147)}, lipid formulations of amphotericin B, a lipid formulation of nystatin, echinocandins {anidulafungin (formerly, LY-303366, VER-002), caspofungin (formerly MK-991), micafungin (formerly FK-463)}, antifungal peptides other than echinocandins, and sordarin derivatives. This discussion reviews the currently available antifungal agents and summarises the developmental issues that surround these new systemic antifungal drugs1.Keywords
This publication has 277 references indexed in Scilit:
- Sordarin antifungal agentsExpert Opinion on Therapeutic Patents, 2001
- Pharmacology of ItraconazoleDrugs, 2001
- Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of readingDiagnostic Microbiology and Infectious Disease, 2000
- Terbinafine: An updateJournal of the American Academy of Dermatology, 1997
- Clinical Pharmacokinetics of FluconazoleClinical Pharmacokinetics, 1993
- Liposomal and Lipid Formulations of Amphotericin BClinical Pharmacokinetics, 1992
- Systemically Administered Antifungal AgentsDrugs, 1992
- In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agentsDiagnostic Microbiology and Infectious Disease, 1992
- Infection in cancer patients: A continuing associationThe American Journal of Medicine, 1986
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979